Which of the following is not a requirement of USP <800> for an entity’s HD list? A. must be reviewed every 12 weeks B. must include any items on the current NIOSH list of antineoplastics and other HDs C. must contain investigational drugs that are evaluated to potentially be hazardous D. none of the above
Which of the following is not a requirement of USP <800> for an entity’s HD list
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.
